AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
ORLANDO, FLA. -- Pregnancy does not cause relapse in patients with inflammatory bowel disease, and standard IBD treatments during pregnancy do not increase the risk of adverse fetal outcomes, a prospective case-control study suggests.
The findings of the 20-year study may give some peace of mind to the many women with IBD who are concerned about the effects of treatment on their fetus, and about the effects of pregnancy on the course of their disease. The data regarding treatment effects and pregnancy outcomes in IBD have been scant and based only on cohort studies and registry data. Flavio M. Habal, M.D. said at the annual meeting of the American College of Gastroenterology.
He compared outcomes in 138 women with IBD who gave birth to a total of 174 infants over the course of the study, 83 case-matched nonpregnant controls with IBD, and 100 healthy pregnant controls.
IBD relapses occurred in 18% of the case patients, compared with 23% of the control patients with IBD. The difference was not statistically ...
Source: HighBeam Research, IBD therapy appears to be safe in pregnancy.(Obstetrics)